Analysis of Physical Transformation of API During Manufacture and Storage

[1]  H. Brittain,et al.  Spectral methods for the characterization of polymorphs and solvates. , 1997, Journal of pharmaceutical sciences.

[2]  B. Hortling,et al.  Cross polarization — magic angle spinning NMR studies of carbohydrates and aromatic polymers , 1985 .

[3]  Manfred Koch,et al.  Mathematical Correction for Variable T1H Relaxation of Overlapping Signals in Solid State 13C Cross Polarization NMR Spectroscopy , 1993, Comput. Chem..

[4]  X. Zhou,et al.  Moisture determination in hygroscopic drug substances by near infrared spectroscopy. , 1998, Journal of pharmaceutical and biomedical analysis.

[5]  E. R. Andrew.  Magic Angle Spinning , 1981 .

[6]  A. Eustaquio,et al.  Quantification of paracetamol in intact tablets using near-infrared transmittance spectroscopy. , 1998, The Analyst.

[7]  H. Vromans,et al.  The use of 13C labeling to enhance the sensitivity of 13C solid-state CPMAS NMR to study polymorphism in low dose solid formulations. , 2005, Journal of pharmaceutical sciences.

[8]  Jack L. Johnson,et al.  Quantitative X-Ray Powder Diffraction Method Using the Full Diffraction Pattern , 1987, Powder Diffraction.

[9]  J. Guillory,et al.  Polymorphism in sulfonamides. , 1972, Journal of pharmaceutical sciences.

[10]  Edward V. Thomas,et al.  A primer on multivariate calibration , 1994 .

[11]  D. Bugay,et al.  Quantitation of cefepime.2HCl dihydrate in cefepime.2HCl monohydrate by diffuse reflectance IR and powder X-ray diffraction techniques. , 1996, Journal of pharmaceutical and biomedical analysis.

[12]  L. Alexander,et al.  Basic Aspects of X-Ray Absorption In Quantitative Diffraction Analysis of Powder Mixtures , 1948, Powder Diffraction.

[13]  H. Toraya,et al.  Quantitative Phase Analysis using the Whole-Powder-Pattern Decomposition Method. I. Solution from Knowledge of Chemical Compositions , 1995 .

[14]  R. D. Jee,et al.  The application of multiple linear regression to the measurement of the median particle size of drugs and pharmaceutical excipients by near-infrared spectroscopy. , 1998, The Analyst.

[15]  J. Fricke,et al.  Effective Sample Size in Diffuse Reflectance Near-IR Spectrometry. , 1999, Analytical chemistry.

[16]  W. Bragg,et al.  The Structure of Some Crystals as Indicated by Their Diffraction of X-rays , 1913 .

[17]  P. Kubelka.  Ein Beitrag zur Optik der Farban striche , 1931 .

[18]  G. Maciel,et al.  Setting the magic angle using a quadrupolar nuclide , 1982 .

[19]  C Piantadosi,et al.  Antitumor agents. I. Augustibalin, a new cytotoxic sesquiterpene lactone from Balduina angustifolia (Pursh.) Robins. , 1972, Journal of pharmaceutical sciences.

[20]  Cecil Dybowski,et al.  Quantification of 13C in solids using CPMAS-DD-NMR spectroscopy , 1993 .

[21]  M. Walters,et al.  Characterization of polymorphs of a new anti-inflammatory drug. , 1993, Journal of pharmaceutical and biomedical analysis.

[22]  Tom Artursson,et al.  Study of Preprocessing Methods for the Determination of Crystalline Phases in Binary Mixtures of Drug Substances by X-ray Powder Diffraction and Multivariate Calibration , 2000 .

[23]  W. A. Dollase,et al.  Correction of intensities for preferred orientation in powder diffractometry: application of the March model , 1986 .

[24]  David L. Bish,et al.  FULLPAT: a full-pattern quantitative analysis program for X-ray powder diffraction using measured and calculated patterns , 2002 .

[25]  J. Sjöblom,et al.  Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound. , 1997, Journal of pharmaceutical and biomedical analysis.

[26]  Alexander Pines,et al.  Proton‐enhanced NMR of dilute spins in solids , 1973 .

[27]  J W SHELL,et al.  X-ray and crystallographic applications in pharmaceutical research. I. Trace element determinations by x-ray emission. , 1962, Journal of pharmaceutical sciences.

[28]  Robin K. Harris,et al.  Quantitative aspects of high-resolution solid-state nuclear magnetic resonance spectroscopy , 1985 .

[29]  G. R. Hays.  High-resolution carbon-13 solid-state nuclear magnetic resonance spectroscopy , 1982 .

[30]  J. Coello,et al.  Effect of Data Preprocessing Methods in Near-Infrared Diffuse Reflectance Spectroscopy for the Determination of the Active Compound in a Pharmaceutical Preparation , 1997 .

[31]  R. B. Barnes,et al.  Organic Quantitative Analysis Using Geiger Counter X-Ray Spectrometer , 1948 .

[32]  D. Bugay,et al.  Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. , 1998, Journal of pharmaceutical and biomedical analysis.

[33]  J W SHELL.  X-ray and crystallographic applications in pharmaceutical research. II. Quantitative x-ray diffraction. , 1963, Journal of pharmaceutical sciences.

[34]  S. Hansen,et al.  Determination of opium alkaloids in opium by capillary electrophoresis. , 1995, Journal of pharmaceutical and biomedical analysis.

[35]  Peter R. Griffiths,et al.  Diffuse reflectance measurements by infrared Fourier transform spectrometry , 1978 .

[36]  W. Dixon,et al.  Spinning‐sideband‐free and spinning‐sideband‐only NMR spectra in spinning samples , 1982 .

[37]  David M. Grant,et al.  Cross polarization and magic angle sample spinning NMR spectra of model organic compounds. 2. Molecules of low or remote protonation , 1983 .

[38]  David M. Grant,et al.  Cross polarization and magic angle sample spinning NMR spectra of model organic compounds. 1. Highly protonated molecules , 1983 .

[39]  Jack L. Koenig,et al.  Applications of High-Resolution Carbon-13 Nuclear Magnetic Resonance Spectroscopy to Solid Polymers , 1983 .